病理性股骨近端骨折半髋关节置换与全髋关节置换术后短期发病率与死亡率比较
本研究基于2007至2017年美国国家外科质量改进计划数据库,比较病理性股骨近端骨折患者接受半髋关节置换与全髋关节置换的30天发病率与死亡率。经倾向性调整回归分析,全髋关节置换手术时间较长(120.3±5.6 vs 98.7±4.9分钟,P<.001),但两种术式在30天主要并发症、次要并发症、再手术、再入院及死亡方面无显著差异。作者认为全髋关节置换可用于治疗部分病理性股骨近端骨折患者,未来需研究长期功能结局。
要点
- 全髋关节置换与半髋关节置换治疗病理性股骨近端骨折的30天并发症和死亡率无显著差异。
- 全髋关节置换手术时间较长(120.3±5.6 vs 98.7±4.9分钟,P<.001)。
- 高龄、功能依赖状态和播散性癌症是选择半髋关节置换的独立预测因素。
核心结论
- 在控制潜在混杂因素后,全髋关节置换与半髋关节置换治疗病理性股骨近端骨折的30天并发症无显著差异。
- 作者认为全髋关节置换可用于治疗部分病理性股骨近端骨折患者,未来需研究长期功能结局。
研究设计与样本
- 回顾性数据库研究,查询美国国家外科质量改进计划数据库2007至2017年数据。
- 纳入病理性股骨近端骨折接受半髋关节置换或全髋关节置换的患者。
- 采用倾向性调整逻辑回归比较30天发病率与死亡率,并使用向后逐步回归确定半髋关节置换的独立预测因素。
主要发现
- 全髋关节置换组手术时间120.3±5.6分钟 vs 半髋关节置换组98.7±4.9分钟(P<.001)。
- 全髋关节置换与半髋关节置换的30天主要并发症无差异(P=.3)。
- 全髋关节置换与半髋关节置换的30天次要并发症无差异(P=.77)。
- 全髋关节置换与半髋关节置换的30天再手术(P=.99)、再入院(P=.35)及死亡(P=.63)均无差异。
- 高龄(P<.001)、功能依赖状态(P=.02)和播散性癌症(P=.049)是接受半髋关节置换而非全髋关节置换的预测因素。
临床怎么用
- 作者认为全髋关节置换可用于治疗部分病理性股骨近端骨折患者。
局限性
- 未来需研究长期功能结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As oncology patients have increasing life expectancies, total hip arthroplasty (THA) may become an important treatment option for pathologic proximal femur fractures (PPFFs). Although THA and hemiarthroplasty (HA) have been compared for native hip fracture treatment, no data on short-term morbidity and mortality are available in the pathologic setting. The purpose of this study is to compare short-term morbidity and mortality of HA vs THA for PPFFs. METHODS: The National Surgical Quality Improvement Program database was queried from 2007 to 2017 for patients with PPFFs treated with HA or THA. Propensity-adjusted logistic regressions were implemented to compare 30-day morbidity and mortality between procedures. Backwards stepwise regression was then used to determine independent predictors of treatment with HA compared to THA. RESULTS: In adjusted analysis, THA was associated with longer operative times (120.3 ± 5.6 vs 98.7 ± 4.9 minutes, P < .001); however, there were no differences between THA and HA with regard to 30-day rates of major complications (P = .3), minor complications (P = .77), reoperations (P = .99), readmissions (P = .35), or deaths (P = .63). Older age (P < .001), dependent functional status (P = .02), and the presence of disseminated cancer (P = .049) were predictive of undergoing HA compared to THA. CONCLUSION: As patients with metastatic cancer continue to live longer with their disease, the durability of surgical reconstruction to treat PPFFs is becoming increasingly important. This study demonstrated no significant differences in 30-day complications between PPFF patients treated with THA or HA after controlling for underlying confounders. These results suggest that THA can be utilized to treat certain patients with PPFFs, and future work is warranted to examine long-term functional outcomes.
引用
- Varady NH, Ameen BT, Hayden BL, et al. Short-Term Morbidity and Mortality After Hemiarthroplasty and Total Hip Arthroplasty for Pathologic Proximal Femur Fractures. J Arthroplasty. 2019. PMID: 31279601. doi:10.1016/j.arth.2019.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。